Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
about
Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcriptionInnate immune targets of hepatitis B virus infectionLinks between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular CarcinomaHepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected HepatocyteStable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B VirusInterplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathwaysEctopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cellsPossible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection.Innate antiviral immune responses to hepatitis B virus.The tug-of-war between dendritic cells and human chronic viruses.Sphingosine kinase 1 in viral infections.Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.HBV and the immune response.How to achieve immune control in chronic hepatitis B?Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus.Immune Response in Hepatitis B Virus Infection.Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.Acetaldehyde accelerates HCV-induced impairment of innate immunity by suppressing methylation reactions in liver cells.Protein phosphatase 2A impairs IFNα-induced antiviral activity against the hepatitis C virus through the inhibition of STAT1 tyrosine phosphorylation.Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein.Control of hepatitis B virus replication by innate response of HepaRG cells.Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.Mechanisms of Hepatitis B Virus Persistence.Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages.Differential expression of innate immune response genes in clinical phases of chronic hepatitis B infection.Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A.Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1.Characterization of microRNA expression profiles associated with hepatitis B virus replication and clearance in vivo and in vitro.Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies.Interplay between hepatitis B virus and innate immune signaling pathwaysPost-translational Modification Control of HBV Biological Processes
P2860
Q24634260-B17AF9FB-00EC-4965-A32C-0880124036ECQ26743647-773AC76A-18B0-46B8-8AAE-3935B16AF28AQ26744497-CAE1AC6E-4141-4083-862D-427A8F935E5FQ26775635-EDC55494-AE19-46F5-A18A-2C9FD8F4C837Q28551711-123F494F-9E19-4170-B035-229B344CC2B1Q30854409-A70768A3-87C6-4E6D-ABD2-5A576CB5ED24Q35115583-C9A78BFB-8192-4C30-86A3-55C18F187EE9Q35203879-B53F21B9-38FC-49B3-9285-B4D3B0344FBFQ35343911-F895015D-943F-4FF0-9C53-3EC76A05A803Q35779946-B30ABE3B-1848-487A-A692-0045E6686600Q36073739-24B8E707-76A7-45EC-9B8A-2DC32905236DQ36381558-D53DDCB0-E201-400A-A6A3-FB85BA663A8BQ36623471-19E7C5D8-8972-49C0-9921-18334399795BQ37547706-E3E14612-F94F-4CAE-B1BE-93E65494D85FQ37945209-FD141614-8B98-46D1-9454-93494B218804Q37952807-6EEB2551-7153-4838-9309-67A8F8A59D59Q38013700-ADD0BBBC-7CC1-43F4-B55D-7A255361CD94Q38180983-10749E0D-6DEC-4BB0-9055-13C70571A3B9Q38295864-9E8DA487-F224-4B01-9A70-7A132072EF53Q38383489-22FB012F-DFA0-43E3-80A0-7A987AEE09A4Q38498898-1A738E3B-0B73-4199-A517-2D1807B21C2BQ38541811-FC285575-FA0D-4FEA-9DE3-A57271BC78FFQ38837061-F900E080-C92F-400B-9949-0D6116D285C7Q38845625-A8B87A9B-F22E-4597-AB52-A268F1ADB72DQ39116339-0837B489-5124-4CFA-A15D-49B53EE68576Q39274712-047425B1-7991-4319-8ED7-63F226CCAFDDQ39410081-EF35ECF1-72D2-4C64-B4FC-312B22F7C0E2Q39611090-5E0F38B4-861B-42F6-A1BC-3930F59F6CDFQ39781596-11FAB786-FC05-4F10-9339-334E954239C5Q40051813-506C21A3-6547-4DD7-8E1D-C72AA1F21FAEQ40077350-4E7CDDF9-619D-4B1A-B848-814B1BBCEC5AQ40127647-9AF5DCFB-8166-4B88-AF08-322DBFEE8AEDQ40139996-01087637-6123-4C5D-B746-18B6C070C26EQ40325365-3BCFDA51-4413-4F76-AF58-40CEB9D7BABCQ40599506-48310409-7385-4AAA-9B52-7AA39BD72647Q42249714-2285A026-B316-417E-9F9D-ADBB3247272CQ44824138-E0E229C4-B9EB-47C9-815A-AD19BD2F9FAFQ45357002-7EC497C3-94AA-46BE-A4AF-842E76767788Q57207207-9B258741-A597-4209-B7EA-D4CD7398FB64Q59137720-83F72D7E-3FC9-42A6-9D3B-C3D40146E229
P2860
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@ast
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@en
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@nl
type
label
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@ast
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@en
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@nl
prefLabel
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@ast
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@en
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@nl
P2093
P2860
P3181
P356
P1433
P1476
Inhibition of Alpha Interferon Signaling by Hepatitis B Virus
@en
P2093
Christine Bernsmeier
Dianxing Sun
Francois Duong
Verena Christen
P2860
P304
P3181
P356
10.1128/JVI.01292-06
P577
2007-01-01T00:00:00Z